(Q47808177)

5 February 2018

title

High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy (English)

1 reference

5 February 2018

inflammatory bowel diseases

main subject

patient

0 references

inflammation

0 references

1 reference

5

Stephan R Targan

1 reference

5 February 2018

author name string

William S Mow

1

1 reference

5 February 2018

Maria T Abreu-Martin

2

1 reference

5 February 2018

Konstantinos A Papadakis

3

1 reference

5 February 2018

Howard E Pitchon

4

1 reference

5 February 2018

Eric A Vasiliauskas

6

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

5 February 2018

Clinical Gastroenterology and Hepatology

published in

1 reference

5 February 2018

volume

2

1 reference

5 February 2018

issue

4

1 reference

5 February 2018

page(s)

309-313

1 reference

5 February 2018

Tumor necrosis factor: biology and therapeutic inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Role of cytokines in the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Reactivation of histoplasmosis after treatment with infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

IL-10-producing T cells suppress immune responses in anergic tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Changes in the transmission of tuberculosis in New York City from 1990 to 1999

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Tuberculosis--the global view

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Reliability of tuberculin purified derivative skin testing and delayed-type hypersensitivity skin test anergy in HIV-infected homosexual men, at risk of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Tuberculosis infection and anergy in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Immunological basis for reactivation of tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

Classification of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

The differential diagnosis of idiopathic inflammatory disease by colorectal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

A simple classification of Crohn's disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900060-6

7 January 2021

10.1016/S1542-3565(04)00060-6

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018